1.Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients.
Seonghoon CHOI ; Hee Sun MUN ; Min Kyung KANG ; Jung Rae CHO ; Seong Woo HAN ; Namho LEE
The Korean Journal of Internal Medicine 2015;30(1):49-55
BACKGROUND/AIMS: In the bare-metal stent era, routine follow-up coronary angiography (RFU CAG) was used to ensure stent patency. With the advent of drug-eluting stents (DESs) with better safety and efficacy profiles, RFU CAG has been performed less often. There are few data on the clinical impact of RFU CAG after second- or third-generation DES implantation in clinically stable patients with coronary artery disease; the aim of this study was to examine this issue. METHODS: We analyzed clinical outcomes retrospectively of 259 patients who were event-free at 12-month after stent implantation and did not undergo RFU CAG (clinical follow-up group) and 364 patients who were event-free prior to RFU CAG (angiographic follow-up group). Baseline characteristics were compared between the groups. RESULTS: The Kaplan-Meier estimated total survival and major adverse cardiac event (MACE)-free survival did not differ between the groups (p = 0.100 and p = 0.461, respectively). The cumulative MACE rate was also not different between the groups (hazard ratio, 0.85; 95% confidence interval, 0.35 to 2.02). In the angiographic follow-up group, 8.8% revascularization was seen at RFU CAG. CONCLUSIONS: RFU CAG did not affect long-term clinical outcome after second- or third-generation DES implantation in clinically stable patients.
Aged
;
*Coronary Angiography
;
Coronary Artery Bypass
;
Coronary Artery Disease/radiography/*therapy
;
Coronary Restenosis/etiology/radiography/surgery
;
Coronary Vessels/*radiography
;
Disease Progression
;
Disease-Free Survival
;
*Drug-Eluting Stents
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Myocardial Infarction/etiology/radiography/surgery
;
Patient Selection
;
Percutaneous Coronary Intervention/adverse effects/*instrumentation
;
Predictive Value of Tests
;
Proportional Hazards Models
;
Prosthesis Design
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Treatment Outcome
2.Prediction of Coronary Atherosclerotic Ostial Lesion with a Damping of the Pressure Tracing during Diagnostic Coronary Angiography.
Ae Young HER ; Soe Hee ANN ; Gillian Balbir SINGH ; Yong Hoon KIM ; Bon Kwon KOO ; Eun Seok SHIN
Yonsei Medical Journal 2016;57(1):58-63
PURPOSE: When performing coronary angiography (CAG), diagnostic catheter intubation to the ostium can cause damping of the pressure tracing. The aim of this study was to determine the predictors of atherosclerotic ostial stenosis in patients showing pressure damping during CAG. MATERIALS AND METHODS: In total, 2926 patients who underwent diagnostic CAG were screened in this study. Pressure damping was defined as an abrupt decline of the coronary blood pressure with a blunted pulse pressure after engagement of the diagnostic catheter. According to CAG and intravascular ultrasound (IVUS), we divided damped ostia into two groups: atherosclerotic ostial lesion group (true lesion group) and non-atherosclerotic ostium group (false lesion group). Clinical and angiographic characteristics were compared between the two groups. RESULTS: The overall incidence of pressure damping was 2.3% (68 patients and 76 ostia). Among the pressure damped ostia, 40.8% (31 of 76 ostia) were true atherosclerotic ostial lesions (true lesion group). The true lesion group had more frequent left main ostial damping and more percutaneous coronary interventions (PCIs) performed on non-ostial lesions, compared to the false lesion group. On multivariate logistic regression analysis, left main ostial damping [hazard ratio (HR) 4.11, 95% confidence interval (CI) 1.24-13.67, p=0.021] and PCI on non-ostial lesion (HR 5.34, 95% CI 1.34-21.27, p=0.018) emerged as independent predictors for true atherosclerotic ostial lesions in patients with pressure damping. CONCLUSION: Left main ostial damping and the presence of a non-ostial atherosclerotic lesion may suggest a significant true atherosclerotic lesion in the coronary ostium.
Aged
;
*Coronary Angiography
;
Coronary Artery Disease/etiology/*radiography
;
Coronary Occlusion/diagnosis/*therapy
;
Coronary Stenosis/etiology/*radiography
;
Coronary Vessel Anomalies/radiography
;
Coronary Vessels/*pathology
;
Female
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Percutaneous Coronary Intervention/adverse effects/methods
;
Predictive Value of Tests
;
Proportional Hazards Models
;
Radiography, Interventional
3.The Role of Optical Coherence Tomography in Coronary Intervention.
Mitsuyasu TERASHIMA ; Hideaki KANEDA ; Takahiko SUZUKI
The Korean Journal of Internal Medicine 2012;27(1):1-12
Optical coherence tomography (OCT) is an optical analog of intravascular ultrasound (IVUS) that can be used to examine the coronary arteries and has 10-fold higher resolution than IVUS. Based on polarization properties, OCT can differentiate tissue characteristics (fibrous, calcified, or lipid-rich plaque) and identify thin-cap fibroatheroma. Because of the strong attenuation of light by blood, OCT systems required the removal of blood during OCT examinations. A recently developed frequency-domain OCT system has a faster frame rate and pullback speed, making the OCT procedure more user-friendly and not requiring proximal balloon occlusion. During percutaneous coronary intervention (PCI), OCT can provide detailed information (dissection, tissue prolapse, thrombi, and incomplete stent apposition [ISA]). At follow-up examinations after stent implantation, stent strut coverage and ISA can be assessed. Several OCT studies have demonstrated delayed neointimal coverage following drug-eluting stent (DES) implantation vs. bare metal stent (BMS) placement. While newer DESs promote more favorable vascular healing, the clinical implications remain unknown. Recent OCT studies have provided insights into restenotic tissue characteristics; DES restenotic morphologies differ from those with BMSs. OCT is a novel, promising imaging modality; with more in-depth assessments of its use, it may impact clinical outcomes in patients with symptomatic coronary artery disease.
*Angioplasty, Balloon, Coronary/adverse effects/instrumentation
;
Coronary Angiography
;
Coronary Artery Disease/*pathology/radiography/*therapy/ultrasonography
;
Coronary Restenosis/etiology/pathology
;
Coronary Vessels/*pathology/ultrasonography
;
Humans
;
Predictive Value of Tests
;
Severity of Illness Index
;
Stents
;
*Tomography, Optical Coherence
;
Treatment Outcome
;
Ultrasonography, Interventional
4.2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: A Joint Report of the Korean Society of Cardiology and the Korean Society of Radiology.
Yeonyee E YOON ; Yoo Jin HONG ; Hyung Kwan KIM ; Jeong A KIM ; Jin Oh NA ; Dong Hyun YANG ; Young Jin KIM ; Eui Young CHOI
Korean Journal of Radiology 2014;15(6):659-688
Cardiac magnetic resonance (CMR) imaging is now widely used in several fields of cardiovascular disease assessment due to recent technical developments. CMR can give physicians information that cannot be found with other imaging modalities. However, there is no guideline which is suitable for Korean people for the use of CMR. Therefore, we have prepared a Korean guideline for the appropriate utilization of CMR to guide Korean physicians, imaging specialists, medical associates and patients to improve the overall medical system performances. By addressing CMR usage and creating these guidelines we hope to contribute towards the promotion of public health. This guideline is a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.
Cardiomyopathies/diagnosis/radiography
;
Cardiotonic Agents/therapeutic use
;
Chest Pain/complications/diagnosis/radiography
;
Coronary Artery Bypass
;
Coronary Artery Disease/*diagnosis/drug therapy/radiography
;
Dobutamine/therapeutic use
;
Echocardiography
;
Heart Defects, Congenital/diagnosis/radiography
;
Heart Failure/diagnosis/ultrasonography
;
Humans
;
*Magnetic Resonance Imaging
;
Mucocutaneous Lymph Node Syndrome/complications/diagnosis
;
Percutaneous Coronary Intervention
;
Prognosis
;
Risk Assessment
;
Ventricular Function, Left/physiology
5.Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents.
Woong Gil CHOI ; Soo Hyun KIM ; Hyung Seok YOON ; Eun Joo LEE ; Dong Woon KIM
The Korean Journal of Internal Medicine 2015;30(1):42-48
BACKGROUND/AIMS: Although drug-eluting stents (DESs) effectively reduce restenosis following percutaneous coronary intervention (PCI), they also delay re-endothelialization and impair microvascular function, resulting in adverse clinical outcomes. Endothelial progenitor cell (EPC) capturing stents, by providing a functional endothelial layer on the stent, have beneficial effects on microvascular function. However, data on coronary microvascular function in patients with EPC stents versus DESs are lacking. METHODS: Seventy-four patients who previously underwent PCI were enrolled in this study. Microvascular function was evaluated 6 months after PCI based on the index of microvascular resistance (IMR) and the coronary flow reserve (CFR). IMR was calculated as the ratio of the mean distal coronary pressure at maximal hyperemia to the inverse of the hyperemic mean transit time (hTmn). The CFR was calculated by dividing the hTmn by the baseline mean transit time. RESULTS: Twenty-one patients (age, 67.2 +/- 9.6 years; male:female, 15:6) with an EPC stent and 53 patients (age, 61.5 +/- 14.7 years; male:female, 40:13) with second-generation DESs were included in the study. There were no significant differences in the baseline clinical and angiographic characteristics of the two groups. Angiography performed 6 months postoperatively did not show significant differences in their CFR values. However, patients with the EPC stent had a significantly lower IMR than patients with second-generation DESs (median, 25.5 [interquartile range, 12.85 to 28.18] vs. 29.0 [interquartile range, 15.42 to 39.23]; p = 0.043). CONCLUSIONS: Microvascular dysfunction was significantly improved after 6 months in patients with EPC stents compared to those with DESs. The complete re-endothelialization achieved with the EPC stent may provide clinical benefits over DESs, especially in patients with microvascular dysfunction.
Aged
;
Blood Flow Velocity
;
Coronary Angiography
;
Coronary Artery Disease/diagnosis/physiopathology/*therapy
;
*Coronary Circulation
;
Coronary Vessels/*physiopathology/radiography
;
Drug-Eluting Stents
;
*Endothelial Progenitor Cells/radiography
;
Female
;
Humans
;
Male
;
Microvessels/*physiopathology/radiography
;
Middle Aged
;
Percutaneous Coronary Intervention/*instrumentation
;
Prosthesis Design
;
*Re-Epithelialization
;
*Stents
;
Time Factors
;
Treatment Outcome
;
Vascular Resistance
6.The Association Between Current Helicobacter pylori Infection and Coronary Artery Disease.
Seung Won JIN ; Sung Ho HER ; Jong Min LEE ; Hee Jeoung YOON ; Su Jin MOON ; Pum Joon KIM ; Sang Hong BAEK ; Ki Bae SEUNG ; Jae Hyung KIM ; Sang Bum KANG ; Jae Hi KIM ; Keon Yeop KIM
The Korean Journal of Internal Medicine 2007;22(3):152-156
BACKGROUND: The role of Helicobacter pylori (H. pylori) in the pathogenesis of coronary artery disease (CAD) is still controversial, and the relation between current H. pylori infection and CAD has not been fully examined. This study evaluated the relation between H. pylori infection as confirmed by gastroduodenoscopic biopsy and CAD. METHODS: We determined the presence of H. pylori infections, via gastroduodenoscopy, in 88 patients of the normal coronary angiographic group and also in 175 patients of the CAD group, and the latter patients had more than 50% coronary stenosis angiographically demonstrated. We excluded those patients with a history of previous H. pylori eradication and/or malignancy. A small piece of tissue from the antrum, which was obtained by gastroduodenoscopic biopsy, was stained by Warthin-starry silver stain. We defined a negative staining result that there was no stained tissue in the sample and the stained tissue was also positive for H. pylori infection. RESULTS: There was no significant difference, except for gender, age, smoking and high density lipoprotein cholesterol (HDL-c), of the demographic and laboratory characteristics between the groups. Twenty seven (30.7%) patients of the normal control group and 71 (40.6%) patients of the CAD group were positive of H. pylori infection, yet there was no statistical difference. We angiographically followed up the 80 patients of the CAD group who were treated by percutaneous coronary intervention (PCI) at 6 to 9 months after their primary intervention. Twenty two (37.9%) of the 58 patients of the H. pylori negative group and 10 (45.5%) of the 22 patients of the H. pylori positive group were treated with reintervention, but reintervention was also not significantly different between the group with H. pylori infection and the group without the infection. CONCLUSIONS: These data indicated that H. pylori infection had a modest influence on CAD and progressive atheroma, but the showed a tendency to increase. Further studies are needed to evaluate the relationship between H. pylori infection and CAD.
Aged
;
Angioplasty, Transluminal, Percutaneous Coronary
;
Biopsy
;
Case-Control Studies
;
Coronary Angiography
;
Coronary Artery Disease/*microbiology/radiography/therapy
;
Duodenoscopy
;
Female
;
Gastroscopy
;
Helicobacter Infections/complications/*microbiology/pathology
;
Helicobacter pylori/*isolation & purification
;
Humans
;
Male
;
Middle Aged
;
Pyloric Antrum/pathology
;
Time Factors
7.Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation.
Hye Won LEE ; Han Cheol LEE ; Bo Won KIM ; Mi Jin YANG ; Jin Sup PARK ; Jun Hyok OH ; Jung Hyun CHOI ; Kwang Soo CHA ; Taek Jong HONG ; Sang Pil KIM ; Seunghwan SONG ; Jong Ha PARK
Yonsei Medical Journal 2013;54(6):1313-1320
PURPOSE: Thiazolidinediones are insulin-sensitizing agents that reduce neointimal proliferation and the adverse clinical outcomes associated with percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM). There is little data on whether or not low dose pioglitazone reduces adverse clinical outcomes. MATERIALS AND METHODS: The study population included 121 DM patients with coronary artery disease and they were randomly assigned to 60 patients taking 15 mg of pioglitazone daily in addition to their diabetic medications and 61 patients with placebo after the index procedure with drug-eluting stents (DESs). The primary end points were rate of in-stent restenosis (ISR) and change in atheroma volume and in-stent neointimal volume. The secondary end points were all-cause death, myocardial infarction (MI), stent thrombosis and re-PCI. RESULTS: There were no statistical differences in the clinical outcomes and the rate of ISR between the two groups [all-cause death; n=0 (0%) in the pioglitazone group vs. n=1 (1.6%) in the control group, p=0.504, MI; n=2 (3.3%) vs. n=1 (1.6%), p=0.465, re-PCI; n=6 (10.0%) vs. n=6 (9.8%), p=0.652, ISR; n=4 (9.3%) vs. n=4 (7.5%), p=1.000, respectively]. There were no differences in changes in neointimal volume, percent neointimal volume, total plaque volume and percent plaque volume between the two groups on intravascular ultrasonography (IVUS) study. CONCLUSION: Our study demonstrated that low dose pioglitazone does not reduce rate of ISR, neointimal volume nor atheroma volume in DM patients who have undergone PCI with DESs, despite the limitations of the study.
Aged
;
Coronary Artery Disease/drug therapy/radiography/*therapy
;
Coronary Restenosis/*prevention & control
;
*Drug-Eluting Stents
;
Female
;
Humans
;
Hypoglycemic Agents/therapeutic use
;
Male
;
Middle Aged
;
Thiazolidinediones/administration & dosage/*therapeutic use
8.Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study.
Yun Kyeong CHO ; Seung Ho HUR ; Hyun Tae KIM ; In Cheol KIM ; Hyoung Seob PARK ; Hyuck Jun YOON ; Chang Wook NAM ; Hyungseop KIM ; Seong Wook HAN ; Yoon Nyun KIM ; Kwon Bae KIM
The Korean Journal of Internal Medicine 2009;24(4):323-329
BACKGROUND/AIMS: Recent intravascular ultrasound (IVUS) studies of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have demonstrated a significant reduction in neointimal hyperplasia (NIH) based on simple coronary lesions. In this study, we evaluated the efficacy of SES and PES using IVUS in complex coronary lesions. METHODS: Eighty-seven patients in whom 95 drug-eluting stents (66 SES and 29 PES) were implanted in complex coronary lesions were enrolled in this study. Case selection was based on the availability of IVUS and quantitative coronary angiographic (QCA) examinations at the index procedure and at follow-up. The neointimal volume index (volume/length: NIVI) and percent neointimal volume (% NIV) were calculated. The longitudinal length of stented segments without IVUS-detectable NIH was also evaluated. RESULTS: The baseline patient demographics were similar between the SES and PES groups. At follow-up, no significant differences were observed in the vessel, plaque, or stent volume indices between the two groups. However, the NIVI and % NIV were significantly lower in the SES group (p<0.01). The longitudinal length of stented segments without IVUS-detectable NIH was significantly higher in the SES group (p<0.01). The net gain was significantly larger in the SES group (2.3+/-0.7 vs. 2.0x0.6 mm, p=0.025), while the rate of major adverse cardiac events was similar between the two groups. CONCLUSIONS: Although SES showed significantly greater suppression of NIH at follow-up, both stents were highly effective at inhibiting NIH in complex coronary lesions.
Adult
;
Aged
;
Coronary Angiography
;
Coronary Artery Disease/radiography/*therapy/ultrasonography
;
*Drug-Eluting Stents/adverse effects
;
Female
;
Follow-Up Studies
;
Humans
;
Hyperplasia
;
Male
;
Middle Aged
;
Paclitaxel/*administration & dosage
;
Sirolimus/*administration & dosage
;
Tunica Intima/pathology
;
Ultrasonography, Interventional/*methods
9.Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents.
Jang Won SON ; Ung KIM ; Jong Seon PARK ; Young Jo KIM ; Jae Sik JANG ; Tae Hyun YANG ; Dong Soo KIM ; Dong Kie KIM ; Sang Hoon SEOL ; Doo Il KIM ; Chang Wook NAM ; Seung Ho HUR ; Kwon Bae KIM
The Korean Journal of Internal Medicine 2013;28(1):72-80
BACKGROUND/AIMS: The Taxus Liberte stent (Boston Scientific Co.) evolved from the Taxus Express stent, with enhanced stent deliverability and uniform drug delivery. This study was designed to compare angiographic and clinical outcomes in real-world practice between the Taxus Liberte and Taxus Express stents. METHODS: Between 2006 and 2008, 240 patients receiving the Taxus Liberte stent at three centers were registered and compared to historical control patients who had received the Taxus Express stent (n = 272). After propensity score matching, 173 patients treated with the Taxus Liberte stent and the same number of patients treated with the Taxus Express stent were selected. The primary outcome was a composite of major adverse cardiac events (MACE), including cardiac death, myocardial infarction (MI), ischemia driven target vessel revascularization (TVR), and stent thrombosis (ST) at 1 year. An additional angiographic assessment was conducted at 9 to 12 months. RESULTS: The study showed no significant difference between the Taxus Express and Taxus Liberte stents (death, 1.73% vs. 2.31%, p = 1.000; MI, 0% vs. 1.73%, p = 0.2478; TVR, 2.31% vs. 1.16%, p = 0.6848; and ST, 0% vs. 1.16%, p = 0.4986). The total MACE rate at 1 year did not differ between the groups (4.05% in Taxus Express vs. 4.05% in Taxus Liberte, p = 1.000). In addition, the binary restenosis rate did not differ (2.25% in Taxus Express vs. 1.80% in Taxus Liberte, p = 0.6848). CONCLUSIONS: In real-world experience with the two Taxus stent designs, both stents showed similarly good clinical and angiographic outcomes at 1 year. A long-term follow-up study is warranted.
Aged
;
Angioplasty, Balloon, Coronary/adverse effects/*instrumentation/mortality
;
Cardiovascular Agents/administration & dosage
;
Chi-Square Distribution
;
Coronary Angiography
;
Coronary Artery Disease/mortality/radiography/*therapy
;
Coronary Restenosis/etiology/mortality
;
Coronary Thrombosis/etiology/mortality
;
*Drug-Eluting Stents
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myocardial Infarction/etiology/mortality
;
Paclitaxel/*administration & dosage
;
Propensity Score
;
Prosthesis Design
;
Registries
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Stainless Steel
;
Time Factors
;
Treatment Outcome